Klotho Neurosciences Inc - נכסים נקיים למניה בודדת KLTO

Klotho Neurosciences Inc (KLTO) is developing anti-aging therapy based on the Klotho protein to combat cellular senescence. The book value history on GURU.Markets illustrates the current trend, where 0.14 reflects the latest metric value. The business relies on outsourcing drug synthesis through CMOs, while a neutral geopolitical backdrop ensures the stability of clinical trials for its neuromedicine products.

Investing in Klotho Neurosciences Inc (KLTO) requires a deep analysis of the capital structure to assess the sustainability of neurotherapy development. The current book value per share, reflecting the difference between total assets and liabilities per security, allows for an assessment of the company's intrinsic asset value. This indicator demonstrates how effectively the issuer's resources support the creation of innovative drugs to combat Parkinson's disease and aging.